State Street Corp Cytokinetics Inc Transaction History
State Street Corp
- $2.47 Trillion
- Q4 2024
A detailed history of State Street Corp transactions in Cytokinetics Inc stock. As of the latest transaction made, State Street Corp holds 6,167,340 shares of CYTK stock, worth $310 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,167,340
Previous 6,458,324
4.51%
Holding current value
$310 Million
Previous $341 Million
14.92%
% of portfolio
0.01%
Previous 0.01%
Shares
20 transactions
Others Institutions Holding CYTK
# of Institutions
396Shares Held
122MCall Options Held
3.46MPut Options Held
1.86M-
Black Rock Inc. New York, NY14.7MShares$737 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$599 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.8MShares$540 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.89MShares$396 Million0.07% of portfolio
-
Geode Capital Management, LLC Boston, MA2.84MShares$143 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.73B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...